Join our fearless fight
Insmed is a global biopharmaceutical company that invests in scientific and commercial innovation to transform the lives of patients with serious and rare diseases. We have expertise in all stages of development, from concept to market, and industry-leading global commercial capabilities in the U.S., major EU markets, and Japan.
We have expertise in all stages of development, from concept to market, and industry-leading global commercial capabilities in the U.S., major EU markets, and Japan.
Insmed’s first commercialized product was a top ten non-oncology rare disease launch (based on first-year sales) in the U.S. We’re building on that success with the expansion of our core franchise in the EU and Japan and a robust pipeline of investigational therapies that have the potential to transform patients’ lives.
For further information on our clinical development programs, view the following resources:
View our pipeline Investor Events
Business development areas of interest
We recognize that global experts in the biopharmaceutical and academic fields who share our profound sense of urgency and patient focus can contribute to our mission to bring life-altering therapies to patients with serious and rare diseases.
We actively seek business development opportunities in the following areas:
- Clinical and commercial-stage assets with either first-in-class or best-in-class potential in respiratory and rare diseases
- Research, development, and commercialization collaborations that are strategically aligned with our existing portfolio and rare disease focus
- Technology platforms that are complementary to our research capabilities and further advance our research efforts into breakthrough science
While we are primarily interested in global in-licensing and acquisition opportunities, we would consider high-potential regional opportunities that leverage our commercialization expertise in the U.S., major EU markets, and Japan.
We are not seeking opportunities for re-purposed medicines, products with modest differentiation from Standard of Care, generics and biosimilars, or cosmetic/OTC products.
Our Business Development team is based in the U.S. and covers opportunities globally. We regularly attend major partnering meetings. Reach out to us by email to schedule time to meet or for any partnership inquiries.
Head of Corporate and Business Development